激光治疗青光眼和高眼压(LiGHT)试验:一项多中心随机对照试验的基线患者特征
LiGHT试验是一项前瞻性、非 masking、多中心、实用性随机对照试验,旨在比较选择性激光小梁成形术(SLT)与局部药物治疗作为原发性开角型青光眼(POAG)或高眼压症(OHT)初始治疗的效果。2012至2014年间在英国6个中心招募718例既往未治疗患者,随机分配至初始SLT后药物治疗组或单纯药物治疗组,随访3年,主要结局为EQ-5D-5L。基线特征与其它 landmark 青光眼研究相当。
要点
- LiGHT试验纳入718例POAG或OHT患者,其中POAG 555例、OHT 163例。
- POAG患者平均年龄64岁,OHT患者58岁;70%参与者为白人。
- OHT眼眼压中位数26 mmHg,POAG眼23 mmHg;视野平均偏差中位数分别为-0.81 dB和-2.82 dB。
核心结论
- LiGHT试验是首个在真实世界环境中比较SLT与局部药物治疗作为POAG或OHT初始治疗的随机对照试验。
- LiGHT队列的基线特征与其它 landmark 青光眼研究相当。
研究设计与样本
- LiGHT试验为前瞻性、非 masking、多中心、实用性随机对照试验。
- 2012至2014年间在英国6个中心招募718例既往未治疗的POAG或OHT患者。
- 患者随机分配至初始SLT后药物治疗组或单纯药物治疗组,随访3年,按常规临床实践监测。
- 主要结局为EQ-5D-5L;次要结局包括治疗路径成本与成本效果、青光眼效用指数(GUI)、青光眼症状量表、青光眼生活质量(GQL)、路径有效性、视觉功能、安全性和依从性。
主要发现
- 718例患者中,POAG 555例,OHT 163例;518例患者双眼均符合条件。
- POAG患者平均年龄64岁,OHT患者平均年龄58岁;所有参与者中70%为白人。
- OHT眼眼压中位数26 mmHg,POAG眼眼压中位数23 mmHg。
- OHT眼基线视野平均偏差中位数-0.81 dB,POAG眼-2.82 dB。
- POAG患者与OHT患者在EQ-5D-5DL上无差异;OHT与POAG在GUI上的差异为-0.02,在GQL上的差异为1.23。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The laser in glaucoma and ocular hypertension (LiGHT) trial aims to establish whether initial treatment with selective laser trabeculoplasty (SLT) is superior to initial treatment with topical medication for primary open angle glaucoma (POAG) or ocular hypertension (OHT). DESIGN: LiGHT is a prospective unmasked, multicentre, pragmatic, randomised controlled trial (RCT). PARTICIPANTS: 718 previously untreated patients with POAG or OHT were recruited at 6 UK centres between 2012 and 2014. METHODS: Patients were randomised to initial SLT followed by medical therapy or medical therapy without laser. Participants will be monitored for 3 years, according to routine clinical practice. The primary outcome is EQ-5D-5L. Secondary outcomes are treatment pathway cost and cost-effectiveness, Glaucoma Utility Index (GUI), Glaucoma Symptom Scale, Glaucoma Quality of Life (GQL), pathway effectiveness, visual function, safety and concordance. RESULTS: A total of 555 patients had POAG and 163 OHT; 518 patients had both eyes eligible. The mean age for patients with POAG was 64 years and for OHT 58 years. 70% of all participants were white. Median IOP for OHT eyes was 26 mm Hg and 23 mm Hg for POAG eyes. Median baseline visual field mean deviation was -0.81 dB for OHT eyes and -2.82 dB for POAG eyes. There was no difference between patients with POAG and patients with OHT on the EQ-5D-5DL; the difference between OHT and POAG on the GUI was -0.02 and 1.23 on the GQL. CONCLUSIONS: The LiGHT trial is the first RCT to compare the two treatment options in a real-world setting. The baseline characteristics of the LiGHT cohort compare well with other landmark glaucoma studies. TRIAL REGISTRATION NUMBER: ISRCTN32038223, Pre-results.
引用
- Konstantakopoulou E, Gazzard G, Vickerstaff V, et al. The Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics. Br J Ophthalmol. 2017. PMID: 28982956. doi:10.1136/bjophthalmol-2017-310870
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。